Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
Clinical trial NCT05217537 · COMPLETED
Trial details
- NCT number
- NCT05217537
- Sponsor
- Paratek Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2025-02-27
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.